cis-VZ185
cis-VZ185 serves as a non-degradative control and inactive analog of VZ185 (HY-114322), a dual-target BRD7/BRD9 degrader PROTAC. cis-VZ185 exerts antiproliferative activity against epithelioid sarcoma cells only at high concentrations. cis-VZ185 induces morphological changes in osteosarcoma cells. cis-VZ185 can be used in studies related to epithelioid sarcoma.
(Pink: BRD9 and BRD7 ligand (HY-111905A); Blue: VHL ligand (HY-176302); Black: linker).
For research use only. We do not sell to patients.
- CAS No.: 2306193-98-4
- Formula: C53H67FN8O8S
- Molecular Weight:995.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2306193-98-4
-
Molecular Weight 995.21
-
Formula C53H67FN8O8S
-
SMILES
CN1C=C(C2=CC=NC=C2C1=O)C3=CC(OC)=C(CN4CCN(CCCCCOC5=C(CNC([C@H]6N(C([C@@H](NC(C7(F)CC7)=O)C(C)(C)C)=O)C[C@@H](O)C6)=O)C=CC(C8=C(N=CS8)C)=C5)CC4)C(OC)=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Rasmussen SV, et al. Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology. Clinical and translational medicine. 2022 Jul;12(7):e961. [Content Brief]
[2]. Jiang M, et al. LIN28-Targeting Chromenopyrazoles and Tetrahydroquinolines Induced Cellular Morphological Changes and Showed High Biosimilarity with BRD PROTACs. ChemMedChem. 2025 Jan 02;20(1):e202400547. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)